Cultivated chicken may have gained U.S. regulatory approval in 2023, but it failed to conquer its biggest challenges when it came to price parity and scale, according to annual list of worst in tech from the MIT Technology Review.
Most of the criticism was leveled at Upside Foods, which the list called “a bird in borrowed feathers.” Instead of using giant bioreactors to produce whole textured chicken filets, the company was instead growing skin cells in small laboratory flasks which were then manually formed into the chicken pieces. Read more